Site Map
Japanese
TAISHO PHARMACEUTICAL HOLDINGS
HOME
>
News Releases
> News Releases(2011)
Archives
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
2011
Dec/14/2011
Bisphosphonate Antiresorptive Agent, Ibandronate Sodium Hydrate Injection, Demonstrates Efficacy in Osteoporosis in Phase II/III Trial
Sep/8/2011
Annual Report 2011
Sep/8/2011
Investors' Guide 2011
Sep/1/2011
Notice of Approval of Listing the Shares of Taisho Pharmaceutical Holdings Co., Ltd. on the Tokyo Stock Exchange
Aug/1/2011
Presentation of Fiscal 2011 First Quarter Results
Aug/1/2011
Taisho Completes Acquisition of the Shares of Hoepharma Holdings Sdn. Bhd.
Jul/29/2011
Financial Results for the First Quarter of Fiscal 2011
/
Reference Data
May/19/2011
Presentation of Fiscal 2010 Results
May/13/2011
Notice of Incorporation of Holding Company through Sole-Share Transfer
May/13/2011
Financial Results for Fiscal 2010
/
Reference Data
Apr/20/2011
Notice of Revisions to Fiscal 2010 Full-year Forecasts
Apr/8/2011
Launch of the Osteoporosis Agent “Edirol
®
Capsule”
Apr/7/2011
Acquisition of Shares of Hoepharma Holdings Sdn. Bhd.
Feb/2/2011
Presentation of Fiscal 2010 Third Quarter Results
Jan/31/2011
Financial Results for the 3rd Quarter of Fiscal 2010
/
Reference Data
Jan/27/2011
Taisho Repurchases Treasury Stock on the Open Market, Ends Buyback Program
Jan/21/2011
An Active Vitamin D
3
Derivative “Edirol
®
,”Approved in Japan
Jan/5/2011
Taisho to Repurchase Treasury Stock on the Open Market
Adobe Reader is required to view these files.
Adobe Reader
is distributed free of charge by Adobe Systems Incorporated.
Page Top
Our Company
Corporate Profile
Our Business
Social and Environment Activities
News Releases